Stocks360

InterCure Ltd. (INCR.TA)

Stock analysis · TLV · Healthcare · Drug Manufacturers - Specialty & Generic

Share: Facebook X WhatsApp SMS

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
N/A
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
0.64
Day Range
N/A
52-wk Range
N/A
Avg Volume
N/A
Volume
N/A

InterCure Ltd. (INCR.TA) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent
Nov 16, 2023
EPS $0.11 vs est. $0.85
Missed by $0.74

Proprietary Signals

Signal snapshot temporarily unavailable.

About InterCure Ltd.

InterCure Ltd., alongside its affiliated companies, is actively involved in the medical cannabis industry, operating both domestically in Israel and internationally. Their activities encompass the entire spectrum from research and cultivation to production, marketing, and distribution of medical cannabis products. The company's product line features dried cannabis flowers and an oil-based cannabis extract. Additionally, InterCure allocates investments to the biomedical sector. Established in 1994, the firm's main headquarters are situated in Herzliya, Israel.

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap